#United States #Madison #Cancer Care #Accuray Stellar #Radixact Therapy

Accuray Unveils Groundbreaking Radiotherapy Technology

In a significant advancement for cancer treatment, Accuray Incorporated has announced the launch of its new adaptive radiotherapy solution, the Accuray Stellar™. This innovative tool is designed not just as a conventional system but as an integrated solution that empowers clinical teams with a comprehensive set of resources. With a focus on personalized patient care, the Stellar solution aims to tailor radiotherapy based on the unique requirements of each patient, potentially improving outcomes and enhancing the overall treatment experience.

A New Era In Cancer Treatment

Set to be unveiled at the upcoming 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting in San Francisco, the Accuray Stellar solution is poised to revolutionize the approach to radiotherapy. This technology, an enhancement of the Radixact® Treatment Delivery System, offers a unique capability to adapt treatment plans in real time, ensuring that patients receive the highest level of care that evolves alongside their treatment journey.

Suzanne Winter, the president and CEO of Accuray, expressed the company’s commitment to paving the way for innovations in radiation medicine. “Our goal with Accuray Stellar is to provide clinicians with tools that are easy to implement, making it practical to adopt adaptive radiotherapy techniques throughout a patient's cancer journey. This commitment reflects our dedication to enhancing personalized treatments,” she said.

Key Features of Accuray Stellar

Among its notable features, the Accuray Stellar solution integrates seamlessly with Accuray's existing software and hardware technologies, as well as those of various external vendors. This versatility enhances the array of radiation delivery methods available and streamlines the treatment workflow effectively. Clinicians can utilize a variety of delivery modalities, including:

• - Image-Guided Radiation Therapy (IMRT)
• - Stereotactic Body Radiation Therapy (SBRT)
• - Surface-Guided Radiation Therapy (SGRT)

These techniques are tailored to optimize patient outcomes across common cancers such as breast, prostate, lung, and head and neck cancers, as well as complex treatments like total marrow irradiation.

One of the standout features of Stellar is its capability to account for variations in tumor size or shape and patient movement during the treatment process. The system employs real-time motion tracking and correction features, facilitated by Accuray's Synchrony® technology, to ensure precision in delivering treatment, significantly improving the effectiveness of care.

Advanced Tools for Enhanced Decision-Making

Medical teams will also benefit from the incorporation of Adapt LTE™, powered by Accuray Cenos, which assists clinicians in retrospectively assessing previous treatment plans against original objectives. This tool aids in clarifying clinical pathways and allows for better training and evaluation, fostering confidence in the planning and execution of adaptive technologies.

Additionally, the ClearRT® helical kVCT imaging feature reinforces the effectiveness of Accuray's adaptive radiotherapy technologies. By delivering high-resolution imaging, ClearRT enables healthcare professionals to gain crucial insights regarding the tumor and adjacent anatomy, leading to informed decision-making and comprehensive care strategies.

Conclusion: A Commitment to Innovation

Accuray is dedicated to transforming the landscape of cancer care through continuous innovation in radiation therapy. With the Stellar solution, the company aims to enhance the delivery of personalized treatment plans, ensuring that patients receive the targeted care they need to improve their quality of life. For further information about the Accuray Stellar solution and its capabilities, interested parties can visit Accuray's official website.

With the unveiling of this advanced technology at the ASTRO Annual Meeting, Accuray is set to showcase its commitment to quality and innovative solutions designed to meet the complex needs of cancer treatment.

For media inquiries, reach out to Beth Kaplan, Public Relations Director at Accuray.